Awarded contract
Published
Other therapeutic products
6 suppliers have saved this notice.
Looks like a fit? Save this tender and qualify it in Stotles
Value
3,396,597 EUR
Current supplier
A.T.I.: Advanced Accelerator Applications S.r.l. (A.A.A.) e Iba Molecular Italy S.r.l. – via N. Picinni 2 – 20131 Milano
Description
Fornitura di radiofarmaci per PET-TC occorrenti alla S.C. di Medicina nucleare dell’A.O. Ordine Mauriziano — durata anni 2 (+ 24 mesi eventuale opzione di rinnovo + 6 mesi di eventuale proroga + opzione aumento di 1/5).
Qualify tenders faster with AI summaries - see key details in the Stotles app
Unlock decision maker contacts.
Never miss a tender again
Get alerts, AI summaries and tools to qualify faster
Explore similar pre-tenders, open or awarded contracts
Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.
Farmacia San Leone Magno S.r.l.
784,230 EUR
Published 3 years ago
A.O. Ordine Mauriziano di Torino
3,752,699.06 EUR
Published 3 years ago
Azienda Sanitaria Locale Barletta-Andria-Trani
13,200 EUR
Published 3 years ago
Azienda Sanitaria Locale Barletta-Andria-Trani
2,316,997 EUR
Published 3 years ago
Azienda Sanitaria provinciale di Ragusa
254,017.95 EUR
Published 4 years ago
Awarded
Other therapeutic products
Azienda ospedaliera nazionale SS. Antonio e Biagio e Cesare Arrigo Alessandria
947,412 EUR
Published 5 years ago
Awarded
Other therapeutic products
IRCCS Fondazione Istituto Neurologico Carlo Besta
680,214 EUR
Published 7 years ago
Awarded
Other therapeutic products
Azienda Ospedaliera «Ospedali Riuniti Marche Nord»
8,407,823 EUR
Published 8 years ago
Explore top buyers for public sector contracts
Discover open tenders, contract awards and upcoming contract expiries of thousands of public sector buyers below. Gain insights into their procurement activity, historical purchasing trends and more.
CPV Codes
Sign up to the Stotles Tender Tracker for free
Find even more contracts with advanced search capability and AI powered relevance scoring.